Skip to main content
Yunkang Group Limited logo

Yunkang Group Limited — Investor Relations & Filings

Ticker · 2325 ISIN · KYG9889T1067 HKEX Human health and social work activities
Open in API
Filings indexed 1,527 across all filing types
Latest filing 2023-03-31 Notice of Dividend Amou…
Country HK Hong Kong
Listing HKEX 2325

About Yunkang Group Limited

http://www.yunkanghealth.com

Yunkang Group Limited is a leading medical operation service platform specializing in standardized medical diagnostic services. The company provides comprehensive clinical diagnostic capabilities to collaborative hospitals and integrated healthcare systems (hospital alliances). Its core business lines include diagnostic testing services and diagnostic outsourcing services for medical institutions, as well as diagnostic testing for non-medical clients. Yunkang leverages a nationwide service network and operates independent clinical laboratories (ICLs) across key regions. These ICLs often hold dual international accreditations, such as ISO15189 and CAP, ensuring high-quality, full-range clinical diagnostic support.

Recent filings

Filing Released Lang Actions
FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2022
Notice of Dividend Amount Classification · 100% confidence The document is titled 'FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2022' and contains detailed information about the dividend amount, dividend type, record date, ex-dividend date, payment date, and share registrar details. It does not contain financial statements or comprehensive financial performance data but focuses solely on dividend declaration details. The document length is 3581 characters, which is relatively short and consistent with a dividend announcement rather than a full report. Therefore, this document is best classified as a Notice of Dividend Amount (DIV).
2023-03-31 English
(1) DISCLOSEABLE TRANSACTIONS IN RELATION TO THE SUBSCRIPTIONS AND REDEMPTIONS&#x3b; AND (2) CLARIFICATION REGARDING THE INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2022
Regulatory Filings Classification · 95% confidence The document is an announcement by Yunkang Group Limited regarding discloseable transactions related to subscriptions and redemptions of participating shares in segregated portfolios managed by investment managers. It also includes a clarification regarding the company's interim results for the six months ended June 30, 2022, specifically about reclassification of certain subscription amounts in the financial statements. The document references Listing Rules of the Hong Kong Stock Exchange and discusses the implications of these transactions under those rules. The content is focused on reporting significant transactions and clarifications related to financial results but does not contain full financial statements or detailed financial analysis typical of an Interim/Quarterly Report. It is a regulatory announcement about discloseable transactions and clarifications on prior interim results, fitting the category of Regulatory Filings (RNS) as it does not present the full interim report itself but rather an announcement and clarification related to it.
2023-03-31 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022
Annual Report Classification · 95% confidence The document is titled 'ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022' and contains detailed audited consolidated financial results, including comprehensive income statements, financial position statements, and notes to the consolidated financial statements. It covers the full fiscal year ending December 31, 2022, and includes extensive financial data and analysis. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement or summary. The presence of detailed financial statements and notes confirms this is the official annual report covering company activity and full financial performance for the year. Therefore, the document fits the definition of an Annual Report (10-K). FY 2022
2023-03-31 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 95% confidence The document is a short announcement from Yunkang Group Limited stating the date of a board meeting to approve and publish the annual results for the year ended December 31, 2022, and to consider the payment of a final dividend. It does not contain any financial data or the actual annual report itself. The length is only 1375 characters, which is quite short and typical for an announcement. The document explicitly states the meeting is for approving and publishing the annual results, indicating the report is forthcoming but not included here. Therefore, this is a Report Publication Announcement (RPA) rather than the Annual Report (10-K) or Earnings Release (ER).
2023-03-20 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 28 February 2023. It details movements in authorised/registered share capital, issued shares, and confirms no changes in share options, warrants, convertibles, or other agreements. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share issuance status for a specific month. It is not a financial report, earnings release, or management discussion, but a regulatory filing about share capital movements. The document length is 4431 characters, which is relatively short and consistent with a regulatory filing rather than a full report. Therefore, the best classification is Regulatory Filings (RNS).
2023-03-06 English
Monthly Return of Equity Issuer on Movements in Securities (for the month ended 28 February 2023)
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 28 February 2023. It details movements in issued shares, convertibles, and other share capital information for Lenovo Group Limited. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, focusing on share capital and securities movements rather than financial performance or management commentary. It is not an annual or interim report, earnings release, or management discussion. It is a regulatory filing related to share capital movements and securities, consistent with a regulatory compliance report rather than a financial report or announcement of a report. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2023-03-02 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.